BioAtla, Inc.BCABNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank83
5Y CAGR-15.8%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

5Y CAGR
-15.8%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive growthAccelerating
PeriodValue
202430.84%
2023-15.04%
2022-45.34%
2021-71.23%
2020-276.71%
201972.69%
20180.00%